Genetics and other technological advances are changing cancer diagnostics research, much as they have other areas of medicine, but researchers face, among other hurdles, information overload.
By Wendy Diller
Cancer diagnostics has been marked by grandiose hopes and numbing disappointments. Advances in our understanding of cancer haven't, to date,...
Join thousands of industry professionals who rely on Medtech Insight for daily insights
Already a subscriber?
Archimed will acquire dental implant firm ZimVie for $730m in a deal that reflects private equity’s growing role in medtech M&A, as strategic buyers face antitrust scrutiny. The deal includes a 125% premium and a 40-day window for competing offers.
As AI tools make research fraud and résumé fraud easier than ever, life sciences companies need to take steps to protect themselves. Snedden Campbell CEO Ivor Campbell has some tips on successful strategies.
The Cancer Research Horizons Innovation Awards took place on July 10. Medtech Insight spoke to nominees for the women’s entrepreneur of the year award: Mireia Crispin-Ortuzar, CEO of 52 North Health; Anita Grigoriadis, CEO of PharosAI; and Maria Giovanna Lizio, Founder of WILD-Imaging Technology.
